SCHEMBL6974943

SCHEMBL6974943

O=C(O)C1=CCC2CCOC2=C1

nearest known ligand 0.31

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
GABRR1 P24046 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10372776 0.74
SCHEMBL27992455 0.69
SCHEMBL8959305 0.69 CCR2 (0.34)
SCHEMBL8874669 0.67 GABRR1 (0.39) GABRR1
SCHEMBL6981423 0.67 TSHR (0.37) GABRR1
Hydrochloric Acid SCHEMBL18320900 0.64 LMNA (0.33) GABRR1
SCHEMBL20060386 0.64
SCHEMBL28189342 0.63 L3MBTL1 (0.32)
SCHEMBL6661057 0.62
SCHEMBL11662842 0.62

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109475530-A For treating the aminoacyl indazole immunomodulator of autoimmune disease 洛克菲勒大学 2019-03-15 CN disclosed
EP-1326831-A1 SUBSTITUTED FUSED PYRROLEIMINES AND PYRAZOLEIMINES NEUROGEN CORPORATION (US) 2003-07-16 EP disclosed
WO-2002020480-A1 SUBSTITUTED FUSED PYRROLEIMINES AND PYRAZOLEIMINES NEUROGEN CORPORATION (US) 2002-03-14 WO disclosed